| |
San Antonio, TX, United States, 09/03/2008 – The Technical Insights practice at Frost & Sullivan is pleased to announce its 2008 Quarterly Analyst Briefing Presentation on the North American cancer therapies market to be held on Tuesday September 9, 2008 at 8:00 am PDT.
As paradigms shift and trends emerge in cancer drug developments the “one-size’ fits all approach to cancer therapies is no longer applicable. Therapies now require a tailor fit. Join Frost & Sullivan Research Analyst Sangeetha Prabakar as she discusses current trends in the treatment of oncological diseases.
Pharmaceutical drug manufacturers, biotech firms, CROs, drug delivery and diagnostic firms, and companies who provide technology platform solutions for firms that develop oncology drugs will benefit from attending this briefing. Highlights of the presentation include analyses of cancer drug industry: technology trends, drivers, restraints, emerging opportunities in research and future trends in cancer therapeutics.
“Targeted therapeutics are the emerging trend in cancer therapies that rely on the biological differences between malignant and healthy cells to specifically target only the faulty genes or proteins that play a crucial role in cancer development,” states Frost & Sullivan Research Analyst Sangeetha Prabakar. The burgeoning advances in the field of molecular diagnostics, targeted therapeutics and innovative drug delivery technologies for cancer are expected to lead to a more targeted and personalized cancer care over the next decade.”
To participate, please email Stephanie Ochoa, Corporate Communications, at stephanie.ochoa[.]frost.com with the following information: your full name, title, company name, company telephone number, company email address, city, state and country. Upon receipt of the above information, a registration link will be emailed to you. You may also register to receive a recorded version of the briefing at anytime by submitting the aforementioned contact details.
Frost & Sullivan (frost.com), the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.
|
stephanie.ochoa[.]frost.com 
